Featured Research

from universities, journals, and other organizations

Prostate Cancer Screening Program Leads To Big Fall In Death Rates In Austria's Tyrol Region

Date:
April 22, 2008
Source:
Wiley-Blackwell
Summary:
PSA testing can reduce overall death rates from prostate cancer and early, effective treatment reduces the chance of the disease returning and killing people when they get older. In Austria's Tyrol region, a PSA campaign with an 87 percent uptake rate reduced deaths to almost half the rate of surrounding areas not taking part in the program.

The expected number of deaths from prostate cancer more than halved in the Tyrol region of Austria after a programme was introduced to improve early detection and treatment of the disease, according to research published in April issue of the urology journal BJU International.

Nearly 87 per cent of eligible men have been tested at least once since the programme was introduced in 1988. By 2005 cancer deaths had fallen by 54 per cent, compared with 29 per cent for the rest of Austria, which hadn't benefited from the programme.

There is no evidence that trends in the Tyrol and the rest of Austria were significantly different before free testing was introduced.

"Prostate specific antigen (PSA) testing was introduced to the Tyrol in 1988 and since 1993 it has been freely available to all men aged from 45 to 75 and to men under 40 with a family history of the disease" explains lead author Professor Georg Bartsch from the University of Innsbruck, one of the international team of medical experts that makes up the Tyrol Prostate Cancer Screening Group.

"Our findings suggest that the combination of free PSA testing and free treatment for any resulting prostate cancer can lead to significant reductions in death rates. This free treatment normally involved surgical removal of the prostate.

"What was interesting about this study was that so many men came forward for testing after the programme was widely advertised in the print and broadcast media. People living in the Tyrol -- one of the nine Federal states that make up Austria -- tend to enjoy close proximity to health facilities and be very receptive to preventative medical programmes."

By 2005, just under 87 per cent of men aged between 45 and 75 living in the region had undergone a PSA test.

"Our study clearly shows that deaths from prostate cancer have declined much more quickly in the Tyrol since 1988, when this programme was introduced, compared with the rest of Austria.

"Before the programme was introduced, prostate cancer death rates in the Tyrol were similar to the rest of the country, but after the programme was launched the death rate in the Tyrol started falling by an average of 7.3 per cent a year, more than twice the 3.2 per cent observed in the rest of Austria."

The findings also have important implications for age-related prostate cancer deaths, say the researchers, especially as the number of older men is steadily increasing.

"Deaths from prostate cancer in the 80 plus age group have been increasing across Austria, but there has been no evidence of this happening in the Tyrol" says co-author Professor Boyle from the International Agency for Research on Cancer.

"This indicates that the screening programme in the Tyrol is picking up cases of prostate cancer at an earlier stage of the disease, when it can be treated more effectively. This early treatment reduces the risk of the disease coming back later in life and killing the patient when they are older."

The authors conclude that the introduction of free screening has made an important contribution to reducing prostate cancer death rates in the Tyrol, a region where treatment is freely available to all patients with the disease.

But they acknowledge that there is still controversy surrounding some aspects of screening for prostate cancer that need to be resolved.

These include the effectiveness of PSA testing in all cases, whether aggressive treatment alters the outcome in men with advanced stages of the disease and whether testing and treatment seriously impinge quality of life.

"Our study shows that when widespread PSA testing was introduced to the Tyrol, and people with the disease received free treatment to cure their prostate cancer, the fall in death rates was significantly higher than in the rest of Austria" says Professor Boyle.

"This reduction in death rates is most probably due to the fact that cases of prostate cancer were detected at an earlier stage, when treatment for this disease tends to be more effective.

"However it is important to remember that screening is only the first step in the optimal management of patients with prostate cancer."

Journal reference: Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality. Bartsch et al. BJU International. 101, pp 809-816 (April 2008).


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Prostate Cancer Screening Program Leads To Big Fall In Death Rates In Austria's Tyrol Region." ScienceDaily. ScienceDaily, 22 April 2008. <www.sciencedaily.com/releases/2008/04/080422112950.htm>.
Wiley-Blackwell. (2008, April 22). Prostate Cancer Screening Program Leads To Big Fall In Death Rates In Austria's Tyrol Region. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2008/04/080422112950.htm
Wiley-Blackwell. "Prostate Cancer Screening Program Leads To Big Fall In Death Rates In Austria's Tyrol Region." ScienceDaily. www.sciencedaily.com/releases/2008/04/080422112950.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins